Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE (1) To determine the allele and genotype frequency of the Pro12Ala PPARgamma2 amino acid variant in a Polish population; (2) To search for the association of the Pro12Ala polymorphism with T2DM in the examined population. 14581147 2003
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma is associated with increased leptin levels in women with type-2 diabetes mellitus. 12218380 2002
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Pro12Ala polymorphism of the PPARG2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid. 16920849 2006
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Pro12Ala mutation decreases PPARG activity and resistance to NIDDM. 22937051 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE A common polymorphism (Pro12Ala) of the adipose tissue-specific gamma 2 isoform is associated with increased insulin sensitivity and decreased risk of developing type 2 diabetes. 12643137 2002
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE A functional single nucleotide polymorphism (SNP) that predicts a proline to alanine substitution (Pro12Ala) within the coding region of this gene has previously been associated with obesity and type 2 diabetes in several populations. 12829658 2003
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE A population-attributable risk of approximately 50% for the Pro12Pro genotype indicates that testing for the Pro12Ala of the PPARG gene in addition to the already identified clinical risk factors may become a useful tool to further reduce the risk of PPARgamma agonist-induced fluid retention and edema in patients with type 2 diabetes. 16822823 2006
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE A total of 180 subjects with DR, 193 subjects with type 2 diabetes mellitus (T2DM) with no diabetic retinopathy, and 200 healthy normoglycemic non-retinopathic Pakistani individuals were genotyped for the rs1801282 (c.34C>G) polymorphism using polymerase chain reaction-restriction fragment length polymorphism. 23559865 2013
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Albeit small, our study may suggest that other pathways in AT or effects exerted in other tissues might contribute to the Pro12Ala-mediated protection against T2D. 30064293 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Although cross-sectional studies have associated the Pro12Ala polymorphism of PPARG with type 2 diabetes, prospective studies offer more opportunities to investigate genetic variants. 16567542 2006
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Although no interactions between the four variants on the risk of type 2 diabetes were detected, the multiplicative interaction between PPARG Pro12Ala and HNF4A rs2144908 was found to be associated with 2-hour postprandial insulin (P = 0.004 under an additive model for rs2144908; and P = 0.001 under a dominant model for rs2144908) after adjusting for age, sex and BMI, assuming a dominant model for PPARG Pro12Ala. 20079163 2009
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Although our data indicate that the PPARG2 gene variants, independently, have no association with type 2 diabetes mellitus, the 2-loci genotype analysis involving -1279G/A and Pro12Ala variants and the 3-loci haplotype analysis have shown a significant association with type 2 diabetes mellitus in this South Indian population. 19846173 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Although the study was carried out on a sufficiently large sample, the conclusions do not support a major role for the Pro12Ala substitution of the PPAR-gamma gene in the etiology of type 2 diabetes. 10389855 1999
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Among obese people, there was no association between any of the T2Dm or obesity-related traits and the Pro12Ala polymorphism. 16050954 2005
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Among the genetic factors, a polymorphism (Pro12Ala) in the peroxisome proliferator-activated receptor (PPAR) gamma is associated with a reduced risk of type 2 diabetes mellitus and increased insulin sensitivity, primarily that of lipolysis. 11684868 2001
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Amongst non-obese individuals, we observed significant T2D associations with HNF1A I27L [odds ratio (OR) = 1.14, P = 0.04], GCK -30G>A (OR = 1.23, P = 0.01), SLC30A8 R325W (OR = 0.87, P = 0.04), and TCF7L2 rs7903146 (OR = 1.89, P = 4.5 x 10-23), and non-significant associations with PPARG Pro12Ala (OR = 0.85, P = 0.14), ADIPOQ -11,377C>G (OR = 1.00, P = 0.97) and ENPP1 K121Q (OR = 0.99, P = 0.94). 18498634 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes. 14730381 2004
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE By using a Cox proportional hazard model, common variants in the PPARG (P12A), CAPN10 (SNP43 and 44), KCNJ11 (E23K), UCP2 (-866G>A), and IRS1 (G972R) genes were studied for their ability to predict T2D in 2,293 individuals participating in the Botnia study in Finland. 17570749 2005
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Conflicting evidence exists as to whether the Pro12Ala single nucleotide polymorphism of the type 2 diabetes susceptibility gene peroxisome proliferator-activated receptor gamma (PPARG) also confers risk for type 1 diabetes (T1D). 18466209 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Effect of the PPARG2 Pro12Ala Polymorphism on Associations of Physical Activity and Sedentary Time with Markers of Insulin Sensitivity in Those with an Elevated Risk of Type 2 Diabetes. 25974167 2015
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. 17213274 2007
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes. 21833536 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Four of the nine SNPs revealed a significant association with T2D; PPARG2 (Pro12Ala) [odds ratio (OR) 0.12; 95% confidence interval (CI) (0.03-0.52); p = 0.005], IGF2BP2 [OR 1.37; 95% CI (1.04-1.82); p = 0.027], TCF7L2 [OR 1.64; 95% CI (1.20-2.24); p = 0.001] and FTO [OR 1.46; 95% CI (1.11-1.93); p = 0.007] after adjusting for age, sex and BMI. 18598350 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Further studies of the Pro12Ala variant will determine its relevance to obesity, insulin resistance, and type 2 diabetes. 9425261 1997
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Hence, our aim was to develop a low-cost method for the validation of PPARG (Pro12Ala, CCA>GCA) SNP (rs1801282) for its association with T2D. 25063576 2014